A breast implant is a procedure used to change the size, shape, and curve of a woman’s breast. In reconstructive plastic surgery, breast implants can be placed to restore a natural looking breast embankment for post–mastectomy breast reconstruction patients or to correct ingrained defects and impairment of the chest wall. They are also used cosmetically to enhance or enlarge the appearance of the breast through breast augmentation surgery.
With growing demand for cosmetic surgeries, breast implant market is being growing significantly. Also, women with high preference for enhancing their charming appeal contribute largely to the revenue of breast implantation market. Growing trend of breast augmentation to maintain body proportion and restores breast volume will encourage business growth. Events such as late natural menopause or not bearing children, increases risk of acquiring the cancer due to increased exposure to estrogen and progesterone. Growing awareness pertaining to availability of restoration option have resulted in greater number of women opting for reconstruction procedures. Technological advances and improvements in design and construction will increase the development of innovative devices which cause less rippling or wrinkling. High operational costs with additional expenses of medical tests, post-surgery clothes and medications may stand as a barrier for the growth of this industry. Sometimes re-surgery is required for correcting appearance which further increases patient expenditure. Risk of post-procedural complications may hamper industry expansion.
Breast implants can be segmented on the basis of product, shape, applications, end user and geography.
Based on product, this market is further divided into silicone implant and saline implant. Silicone implants held the largest market due to the fact that these devices tend to be like a natural breast tissue. They are projected to be in demand owing to their soft texture. Ability of the device to replicate the feel of natural breast and lighter weight are the features which increases its popularity. Also, reduction in visible wrinkling or rippling will also fuel segment growth.
By shape, the breast implants market is segmented into round and anatomical. Round-shaped implants contributed toward the largest revenue share in 2016 owing to its round shape and ideal for breast augmentation. Round-shaped implants are symmetrical and eliminate any problem arising at the time of implant rotation. Hence, surgeons also prefer round implants over anatomical implants. Furthermore, anatomical-shaped devices are expected to record significant growth over the forecast period due to its natural shape. However, anatomical-shaped products have certain limitations. Because of its natural shape, it requires skilled surgeons during implantation, failure of which might lead to a risk of flipping. They tend to change the shape of the entire organ, during any shift or rotation of the implant. This may result to an additional surgery for correction.
Based on application, the market can be categorised into breast augmentation and breast reconstruction. Breast augmentation procedures is lined up to witness a significant growth due to increasing number of women opting for it. Short procedural duration and less complications accelerate the demand for this medical intervention. Reconstruction surgery is anticipated to gain significant growth over the forecast period. It usually deals with the defects and deformities of the patient’s chest wall, post mastectomy procedure. This helps in restoring the natural look and enhance their aesthetic appeal.
End users of this market include hospitals, clinics and others. Clinics as end users has an important market share due to large number of surgeries performed in clinical settings. Increasing clinics, availability of skilled medical practitioners and advanced equipment should propel segment growth over the forecast years.
Breast Implant Market by Geography By geography, this market covers North America, Europe, APAC, Latin America and Middle East and Africa. North America dominated the breast implants market owing to the rising healthcare spending in the U.S. Also, rising prevalence of breast cancer in this region is also expected to support the growth of the market. Europe also contributes a significant share due to high awareness levels regarding cosmetic surgeries. Rapidly improving healthcare infrastructure along with rising number of plastic surgeons should serve as high impact rendering factors.
The key competitors of this market include Allergan (Actavis), Sientra Inc., Mentor Worldwide LLC (Johnson & Johnson), Laboratoires Arion, GC Aesthetics, POLYTECH Health and Aesthetics GmbH, Hansbiomed Co. Ltd., Establishment Labs S.A., CEREPLAS, Ideal Implant Inc., Silimed, Guangzhou Wanhe Plastic Materials Co. Ltd., Shanghai Kangning Medical Device Co. Ltd., Groupe Sebbin SAS etc.
The American Society of Plastic Surgeons (ASPS) stated that breast augmentation is one of the top 5 cosmetic procedures conducted in the U.S. According to the ASPS, 279,143 number of procedures related to augmentation of this organ had taken place in the U.S. Thus, with huge number of these cases, the growth of the market is expected to accelerate over the coming years. The global breast implant market has been segmented into product, shape, application, end user and geography. By product, the market is divided into silicone implant and saline implant. Silicone implants held the largest market because these devices tend to be like a natural breast tissue. Unlike the silicone devices, saline do not require any further follow-up sessions with the doctor. However, women who have undergone a silicone breast implantation surgery often suffer from silent implant rupture. Hence, the FDA recommends that such patients need to go for periodic MRI screenings. Based on shape, the global breast implant market is segmented into round and anatomical. Round-shaped implants contributed toward the largest revenue share in 2016 owing to its round shape and ideal for breast augmentation. Anatomical-shaped devices, on the other hand, are expected to witness significant growth over the forecast period due to its natural shape. The design of this type of implant mimics the shape of a natural breast. Women undertaking natural-looking breast enhancement, usually opt for this kind of product. By application, the market is classified into breast augmentation and breast reconstruction. Owing to the rise in number of women opting for breast augmentation, it is expected to witness rapid a growth for the forecast period. Reconstruction medical procedure is foreseen to increase huge development over the conjecture time frame. It manages the imperfections and deformations of the patient's chest wall, post mastectomy system. This aides in re-establishing the common look and improve their stylish interest. Hospitals and clinics are the major end users of the global breast implant market. On the basis of end-user, the hospital segment held the largest market share in 2016 due to increasing preference of patients to be treated in hospitals by plastic surgeons. Moreover, with growing healthcare expenditure, there is a rise in number of hospitals being set up in the developing regions. Geographically, the market is studied for North America, Europe, Asia-Pacific and Rest of the World. Asia Pacific is projected to showcase lucrative growth over the forecast period. This is due to the rising disposable income in the developing countries. Moreover, this region provides a huge opportunity with respect to low-cost treatments in the field of medical tourism. Europe likewise contributed toward huge share in 2016 inferable from the gigantic awareness levels with respect to cosmetic medical procedures. Besides, presentation of an extensive number of cosmetology centres in Europe has likewise upheld the development of this provincial market. Some of the major key players involved in this market are Allergan (Actavis), Sientra Inc., Mentor Worldwide LLC (Johnson & Johnson), Laboratoires Arion, GC Aesthetics, POLYTECH Health and Aesthetics GmbH, Hansbiomed Co. Ltd., Establishment Labs S.A., CEREPLAS, Ideal Implant Inc., Silimed, Guangzhou Wanhe Plastic Materials Co. Ltd., Shanghai Kangning Medical Device Co. Ltd., Groupe Sebbin SAS etc.
Why to buy this report: